[1P-0079] Defining super-enhancers by highly ranked histone H4 multi-acetylation levels identifies transcription factors involved in glioblastoma stemness

^○NANDO DAS¹, JenChien Chang², ChungChau Hon³, S. Thomas Kelly², Shinsuke Ito⁴, Marina Lizio³, Bogumil Kaczkowski⁵, Hisami Watanabe¹, Keisuke Katsushima⁶, Atsushi Natsume⁷, Haruhiko Koseki^{4, 8}, Yutaka Kondo⁶, Aki Minoda², Takashi Umehara^{1, 9} (1.Laboratory for Epigenetics Drug Discovery, RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan, 2.Laboratory for Cellular Epigenomics, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan, 3.Laboratory for Genome Information Analysis, RIKEN IMS, Yokohama, Japan, 4.Laboratory of Developmental Genetics, RIKEN IMS, Yokohama, Japan, 5.Laboratory for Applied Regulatory Genomics Network Analysis, RIKEN IMS, Yokohama, Japan, 6.Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan, 7.Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan, 8.Immune Regulation, Advanced Research Departments, Graduate School of Medicine, Chiba University, Chiba, Japan, 9.PRESTO, Japan Science and Technology Agency, Kawaguchi, Saitama, Japan)

d . エピジェネティクス・クロマチン(1 . 分子)